Please use this identifier to cite or link to this item:
Title: Investigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional management
Authors: Shrestha, Rohit
Tamrakar, Sudichhya
Koju, Pramesh
Maharjan, Sagar
Malla, Subhechhya
Shrestha, Sony Shakya
Citation: ShresthaR., TamrakarS., KojuP., MaharjanS., MallaS., & Shakya ShresthaS. (2023). Investigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional management. Journal of Nepal Health Research Council, 20(4), 942-946.
Issue Date: 2022
Publisher: Government of Nepal; Nepal Health Research Council; Ramshah Path, Kathmandu, Nepal
Keywords: Diacerein
Knee Osteoarthritis
Series/Report no.: Oct-Dec, 2022;4323
Abstract: Abstract Background: Designated as a “priority disease” by World Health Organization, Osteoarthritis is the most common chronic rheumatic disease. Providing a proper treatment for Osteoarthritis is still a major public health challenge. Diacerein has been proposed as a slow acting, symptom modifying or even disease modifying drug used in Osteoarthritis having a risk-benefit ratio far better than conventionally used drugs. However, the evidence of efficacy and safety of use of Diacerein in Osteoarthritis is yet to be explored. Hence, this study attempted to investigate the efficacy and safety of Diacerein in the management of knee osteoarthritis. Methods: This is an analytical cohort study comparing Diacerein with Non-steroidal anti-inflammatory drugs for two months in the management of knee OA. Efficacy was assessed by scores of Lysholm Knee Scoring Scale, Knee injury and Osteoarthritis Outcome Score – Physical Function Short form and Western Ontario and McMaster Universities Osteoarthritis Index. Results: After two months of treatment, the post- treatment scores were significantly superior to the baseline scores in both the treatment groups (p<0.001). There were no significant differences among the post-treatment scores in two different treatment groups (p>0.05). Discoloration of urine and gastritis were the frequently reported adverse effects in Diacerein treatment group and Non-steroidal anti-inflammatory drugs treatment group respectively. Conclusions: Our findings have shown Diacerein is as effective as Non-steroidal anti-inflammatory drugs in treating knee OA patients. Diacerein was generally well tolerated, with a good safety profile. These findings indicate the need for further studies with experimental study design in larger scale. Keywords: Diacerein; Efficacy; Knee Osteoarthritis; NSAIDs; Safety
Description: Original Article
ISSN: Print ISSN: 1727-5482; Online ISSN: 1999-6217
Appears in Collections:Vol 20 No 04 Issue 57 Oct-Dec, 2022

Files in This Item:
File Description SizeFormat 
4323-Manuscript-32175-1-10-20230720.pdfFulltext.337.51 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.